<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03599297</url>
  </required_header>
  <id_info>
    <org_study_id>MAR.UAD.003</org_study_id>
    <nct_id>NCT03599297</nct_id>
  </id_info>
  <brief_title>Bilateral Synchronous Simultaneous Stone Surgery</brief_title>
  <official_title>Evaluation of Efficacy and Safety Profile of Bilateral Synchronous Simultaneous Stone Surgery for Kidney Stones</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Marmara University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Marmara University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Advancements in technology and endourological armamentarium provides multiple surgical
      options for complicated stone patients. To avoid multiple operations and shorten the total
      operation durations, bilateral synchronous simultaneous stone surgery (BSSSS) has been
      popularized in recent years.

      Our aim is to evaluate the preliminary outcomes of BSSSS in patients undergoing supine
      percutaneous nephrolithotomy (PCNL) and retrograde intrarenal surgery (RIRS).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stone free rate</measure>
    <time_frame>at the 24th hour of the surgery</time_frame>
    <description>stone free status is decided according to both the immediate evaluation of the endoscopic view at the end of the operation and the post operative imaging with kidney, ureter, bladder X-ray at the 24th hour of the surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>at the 1st week of surgery</time_frame>
    <description>Complications are assessed according to Clavien Dindo classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post operative urinary diversion</measure>
    <time_frame>at the 24th hour of surgery</time_frame>
    <description>evaluation of patients whether they have a nephrostomy or a ureteral stent at the end of the operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiation exposure</measure>
    <time_frame>At 1st hour of surgery</time_frame>
    <description>The cumulative fluoroscopy dose that was emitted during surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin level change</measure>
    <time_frame>from baseline to 24th hour of surgery</time_frame>
    <description>The amount of hemoglobin drop during and after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>will be assessed through completion of study, an average of 1 year.</time_frame>
    <description>The amount of days that the patient stayed at the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Residual stone</measure>
    <time_frame>at the 24th hour of surgery</time_frame>
    <description>The diameter of the stones that couldn't be retracted</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Kidney Calculi</condition>
  <condition>Nephrolithotomy, Percutaneous</condition>
  <condition>Ureteroscopy</condition>
  <arm_group>
    <arm_group_label>Bilateral synchronous simultaneous stone surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who will be operated for kidney stones at both their kidneys in a single surgery session will be included in the study. Patients will undergo percutaneous nephrolithotomy for one side and flexible ureteroscopy for the other side.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bilateral synchronous simultaneous stone surgery</intervention_name>
    <description>Patients undergoing Bilateral synchronous simultaneous stone surgery (one kidney undergoing percutaneous nephrolithotomy, other kidney undergoing ureteroscopy at the same time in a single patient)</description>
    <arm_group_label>Bilateral synchronous simultaneous stone surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients scheduled for kidney stone surgery according to European Association Urology,
             Urolithiasis guidelines

          -  patients with bilateral kidney stones

        Exclusion Criteria:

          -  none
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yiloren Tanidir, Ass. Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Marmara University, School of Medicine, Department of Urology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yiloren Tanidir, Ass. Prof.</last_name>
    <phone>00905325694275</phone>
    <email>yiloren@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tarik Emre Sener, Urologist</last_name>
    <phone>00905337620712</phone>
    <email>dr.emresener@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Marmara University Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34890</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yiloren Tanidir, Ass.Prof.</last_name>
      <phone>00905325694275</phone>
      <email>yiloren@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Tarik Emre Sener, M.D.</last_name>
      <phone>00905337620712</phone>
      <email>dr.emresener@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>June 4, 2018</study_first_submitted>
  <study_first_submitted_qc>July 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2018</study_first_posted>
  <last_update_submitted>September 22, 2018</last_update_submitted>
  <last_update_submitted_qc>September 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The data can be shared at the end of the study</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>The data will be available at the end of the study (which is planned to be at the end of 2019)</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

